Abacus Planning Group Inc. Has $1.16 Million Position in CVS Health Co. (NYSE:CVS)
Abacus Planning Group Inc. Has $1.16 Million Position in CVS Health Co. (NYSE:CVS)
Abacus Planning Group Inc. raised its holdings in CVS Health Co. (NYSE:CVS – Get Rating) by 5.1% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 12,566 shares of the pharmacy operator's stock after acquiring an additional 608 shares during the quarter. Abacus Planning Group Inc.'s holdings in CVS Health were worth $1,164,000 as of its most recent SEC filing.
據控股頻道報道，Abacus規劃集團在第二季度將其在CVS Health Co.(紐約證券交易所代碼：CVS-GET)的持股比例提高了5.1%。該機構投資者在本季度額外購買了608股後，持有這家藥房運營商的12566股股票。截至最近提交給美國證券交易委員會的文件，算盤規劃集團持有的CVS Health股份價值1,164,000美元。
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. Macroview Investment Management LLC increased its stake in CVS Health by 128.3% in the 1st quarter. Macroview Investment Management LLC now owns 242 shares of the pharmacy operator's stock valued at $25,000 after buying an additional 136 shares during the last quarter. Claremont Financial Group Inc. acquired a new stake in CVS Health in the 4th quarter valued at $26,000. Stuart Chaussee & Associates Inc. increased its stake in shares of CVS Health by 123.0% during the 1st quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator's stock worth $31,000 after purchasing an additional 171 shares during the last quarter. Rise Advisors LLC acquired a new position in shares of CVS Health during the 4th quarter worth about $41,000. Finally, Carl Stuart Investment Advisor Inc. acquired a new position in shares of CVS Health during the 1st quarter worth about $41,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.
其他幾家對衝基金和其他機構投資者最近也增持或減持了CVS的股份。宏景投資管理有限責任公司在第一季度增持了128.3%的CVS Health股份。宏景投資管理公司現在擁有242股這家藥房運營商的股票，價值25,000美元，在上個季度又購買了136股。克萊蒙特金融集團公司在第四季度收購了CVS Health的新股份，價值2.6萬美元。Stuart Chaussee&Associates Inc.在第一季度增持了CVS Health的股份，增幅為123.0%。Stuart Chaussee&Associates Inc.現在持有這家藥房運營商310股股票，價值3.1萬美元，上個季度又購買了171股。Rise Advisors LLC在第四季度收購了CVS Health的新頭寸，價值約41,000美元。最後，卡爾·斯圖爾特投資顧問公司在第一季度收購了價值約41,000美元的CVS Health股票。77.64%的股票目前由機構投資者和對衝基金持有。
CVS Health Price Performance
CVS健康性價比
Shares of NYSE:CVS traded down $1.48 during midday trading on Friday, hitting $98.35. The stock had a trading volume of 4,647,029 shares, compared to its average volume of 4,427,529. The company's 50-day moving average price is $100.20 and its 200-day moving average price is $99.25. The company has a market capitalization of $129.12 billion, a P/E ratio of 15.99, a price-to-earnings-growth ratio of 1.52 and a beta of 0.73. The company has a quick ratio of 0.65, a current ratio of 0.91 and a debt-to-equity ratio of 0.67. CVS Health Co. has a fifty-two week low of $81.78 and a fifty-two week high of $111.25.
紐約證券交易所：CVS的股價在週五午盤交易中下跌1.48美元，觸及98.35美元。該股成交量為4,647,029股，而其平均成交量為4,427,529股。該公司的50日移動均線價格為100.20美元，200日移動均線價格為99.25美元。該公司市值為1,291.2億美元，市盈率為15.99倍，市盈率為1.52倍，貝塔係數為0.73。該公司的速動比率為0.65，流動比率為0.91，債務權益比率為0.67。CVS Health Co.股價為81.78美元，為52周低點，52周高點為111.25美元。
CVS Health Dividend Announcement
CVS健康股息公告
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 1st. Investors of record on Friday, October 21st will be given a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 2.24%. The ex-dividend date is Thursday, October 20th. CVS Health's dividend payout ratio is 35.77%.
該公司最近還披露了季度股息，將於11月1日(星期二)支付。10月21日(星期五)登記在冊的投資者將獲得每股0.55美元的股息。這意味着年化股息為2.20美元，收益率為2.24%。除息日期為10月20日星期四。CVS Health的派息比率為35.77%。
Insider Buying and Selling
內幕買賣
In related news, EVP Alan Lotvin sold 22,541 shares of the company's stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the transaction, the executive vice president now directly owns 109,183 shares in the company, valued at approximately $11,355,032. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other CVS Health news, EVP Thomas M. Moriarty sold 138,654 shares of the company's stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total value of $13,172,130.00. Following the completion of the transaction, the executive vice president now directly owns 626,273 shares in the company, valued at approximately $59,495,935. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Alan Lotvin sold 22,541 shares of the company's stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the transaction, the executive vice president now owns 109,183 shares of the company's stock, valued at $11,355,032. The disclosure for this sale can be found here. 0.69% of the stock is owned by corporate insiders.
在相關新聞中，執行副總裁艾倫·洛文在8月4日(星期四)的一筆交易中出售了22,541股公司股票。這些股票的平均價格為104.00美元，總成交金額為2,344,264.00美元。交易完成後，執行副總裁總裁現在直接持有公司109,183股，價值約11,355,032美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過美國證券交易委員會網站。在CVS Health的其他新聞中，執行副總裁託馬斯·M·莫里亞蒂在6月28日星期二的一筆交易中出售了138,654股該公司股票。這些股票的平均價格為95.00美元，總價值為13,172,130.00美元。交易完成後，執行副總裁總裁現在直接持有該公司626,273股，價值約59,495,935美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可在此超鏈接。此外，執行副總裁艾倫·洛文在8月4日(星期四)的一次交易中出售了22,541股公司股票。這些股票的平均價格為104.00美元，總成交金額為2,344,264.00美元。交易完成後，執行副總裁總裁現在持有該公司109,183股股票，價值11,355,032美元。關於這次銷售的披露可以找到這裏。0.69%的股份由企業內部人士持有。
Analysts Set New Price Targets
分析師設定新的價格目標
Several research analysts have recently weighed in on CVS shares. UBS Group boosted their price objective on shares of CVS Health from $118.00 to $127.00 and gave the stock a "buy" rating in a research note on Thursday, August 4th. Evercore ISI boosted their price objective on shares of CVS Health from $120.00 to $125.00 and gave the stock an "outperform" rating in a research note on Wednesday, September 7th. Credit Suisse Group lifted their target price on shares of CVS Health from $113.00 to $117.00 and gave the stock an "outperform" rating in a report on Monday, August 8th. Loop Capital started coverage on shares of CVS Health in a report on Thursday, June 16th. They set a "buy" rating and a $120.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of CVS Health from $113.00 to $120.00 in a report on Thursday, August 4th. Four investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $117.59.
幾位研究分析師最近紛紛買入CVS股票。瑞銀集團將CVS Health的股票目標價從118.00美元上調至127.00美元，並在週四的一份研究報告中給予該股“買入”評級。9月7日，Evercore ISI將CVS Health的股票目標價從120.00美元上調至125.00美元，並在一份研究報告中給予該股“跑贏大盤”的評級。瑞士信貸集團在8月8日週一的一份報告中將CVS Health的目標價從113.00美元上調至117.00美元，並給予該股“跑贏大盤”的評級。Loop Capital在6月16日星期四的一份報告中開始報道CVS Health的股票。他們為該公司設定了“買入”評級和120.00美元的目標價。最後，德意志銀行Aktiengesellschaft在8月4日週四的一份報告中將CVS Health的目標價從113.00美元上調至120.00美元。四位投資分析師對該股的評級為持有，19位分析師發佈了買入評級，一位分析師對該公司給予了強烈的買入評級。根據MarketBeat的數據，該公司目前的平均評級為“適度買入”，共識目標價為117.59美元。
CVS Health Company Profile
CVS Health公司簡介
(Get Rating)
(獲取評級)
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
CVS Health Corporation在美國提供醫療服務。該公司的醫療福利部門提供傳統的、自願的和以消費者為導向的健康保險產品和相關服務。它為僱主團體、個人、大學生、兼職和小時工、健康計劃、醫療保健提供者、政府單位、政府支持的計劃、勞工團體和外籍人士提供服務。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on CVS Health (CVS)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 2 Semiconductor Stocks To Watch For Reversals
- 免費獲取StockNews.com關於CVS Health(CVS)的研究報告
- 華爾街對Datadog的熱情會帶來巨大的收益嗎？
- MarketBeat：回顧一週9/19-9/23
- 為什麼特斯拉的股票保持彈性？
- 小盤股的裁員是樓市的晴雨表嗎？
- 需要關注的2只半導體類股走勢逆轉
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Get Rating).
想看看還有哪些對衝基金持有簡歷嗎？訪問HoldingsChannel.com獲取CVS Health Co.(紐約證券交易所代碼：CVS-GET Rating)的最新13F文件和內幕交易信息。
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受CVS健康日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對CVS Health和相關公司的最新新聞和分析師評級的每日簡要摘要。